-
The 2022 American College of Cardiology Expert Consensus on the Role of Nonstatin Therapies: An Expert-Guided Tour. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-11-17 Mini G Varughese,Christie M Ballantyne
-
Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: A Brief Review of the Current Landscape. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-11-06 Henry C Zheng,Hamid Afshar
-
Established and Emerging Device Therapy in Heart Failure: Cardiac Contractility Modulation. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-11-02 Justin Haloot,Mihail G Chelu
-
Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac Surgery. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-25 Matthew W Segar,Alexander Marzec,Mehdi Razavi,Karen Mullins,Joanna E Molina-Razavi,Subhasis Chatterjee,Alexis E Shafii,Jennifer R Cozart,Marc R Moon,Abdi Rasekh,Mohammad Saeed
BACKGROUND Postoperative atrial fibrillation (POAF) frequently complicates cardiac surgery. Predicting POAF can guide interventions to prevent its onset. This study assessed the incidence, risk factors, and related adverse outcomes of POAF after cardiac surgery. METHODS A cohort of 1,606 patients undergoing cardiac surgery at a tertiary referral center was analyzed. Postoperative AF was defined based
-
The CardiAMP Cell Therapy for Heart Failure trial. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-23 Carl J Pepine,Amish N Raval
-
Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-23 Jozef Bartunek,Andre Terzic
-
Recovery of Lung Function After 149 Days on Extracorporeal Membrane Oxygenation for COVID-19. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-20 Orlando R Suero,Sri Kartik Valluri,Mario H Farias-Kovac,Leo Simpson,Gabriel Loor,Diana M Guerra,Jose L Diaz-Gomez,Subhasis Chatterjee
This report highlights survival and the patient's perspective after prolonged venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19-related respiratory failure. A 36-year-old man with COVID-19 presented with fever, anosmia, and hypoxia. After respiratory deterioration necessitating intubation and lung-protective ventilation, he was referred for ECMO. After 3 days of conventional venovenous
-
ST-Segment Elevation Myocardial Infarction and Bleeding Complications in JAK2-Negative Polycythemia. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-20 Priscilla Duran Luciano,Vanessa Sabella-Jiménez
Thrombotic and bleeding complications are major causes of morbidity and mortality in patients with polycythemia vera, who predominantly present with an alteration in the JAK2 gene. Because of their hypercoagulable state and risk of hemorrhage, patients with polycythemia vera who present with an acute myocardial infarction pose a challenge to physicians. This case report describes the presentation and
-
Patent Foramen Ovale-Related Hypoxemia After Bilateral Lung Transplant. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-20 Lekhya Raavi,Pankaj Garg,Mohammad Alomari,Mostafa Ali,Ishaq Wadiwala,Magdy M El-Sayed Ahmed
A 64-year-old man with interstitial pulmonary fibrosis and a small patent foramen ovale with right-to-left shunting underwent bilateral lung transplant without closure of the patent foramen ovale. Postoperatively, the patient remained persistently hypoxemic with partial response to high-flow oxygen. Investigations revealed the presence of a large patent foramen ovale with right-to-left shunting on
-
Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-18 Matthew W Segar,Stephanie A Coulter
-
Clinical Impact of Patient-Prosthesis Mismatch After Aortic Valve Replacement With a Mechanical or Biological Prosthesis. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-18 Milos Matkovic,Nemanja Aleksic,Ilija Bilbija,Ana Antic,Jelena Milin Lazovic,Marko Cubrilo,Aleksandar Milojevic,Igor Zivkovic,Svetozar Putnik
BACKGROUND Patient-prosthesis mismatch (PPM) may impair functional capacity and survival after aortic valve replacement. This study aimed to investigate the impact of PPM on long-term survival and quality of life after mechanical and biological aortic valve replacement. METHODS This study included 595 consecutive patients who had undergone isolated aortic valve replacement. Patients were divided into
-
New Biomarkers for Cardiovascular Disease Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Stephanie J. Kim, Fernanda C. P. Mesquita, Camila Hochman-Mendez
Cardiovascular disease is the leading cause of death and disability worldwide. Early detection and treatment of cardiovascular disease are crucial for patient survival and long-term health. Despite advances in cardiovascular disease biomarkers, the prevalence of cardiovascular disease continues to increase worldwide as the global population ages. To address this problem, novel biomarkers that are more
-
Hippo Pathway Knockdown Gene Therapy in the Heart. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Todd R Heallen,James F Martin
-
Targeting Cell Senescence to Improve Cardiac Regeneration. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Georgina M Ellison-Hughes
-
Science Is a Self-Correcting Discipline: Revisiting the Biological Potential of Adult Cardiac Progenitors. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Daniele Torella,Eleonora Cianflone
-
Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Eliana Rosenzweig,Gerson Antonio Valencia Villeda,Sarah Crook,Fatima Koli,Erika B Rosenzweig,Usha S Krishnan
BACKGROUND Patients with pulmonary arterial hypertension have quality-of-life limitations, decreased exercise capacity, and poor prognosis if the condition is left untreated. Standard exercise testing is routinely performed to evaluate patients with pulmonary arterial hypertension but may be limited in its ability to monitor activity levels in daily living. OBJECTIVE To evaluate the validity of the
-
Takotsubo Syndrome in Black Americans: Insights From the National Inpatient Sample. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-17 Olga Vriz,Ali Hassan Mushtaq,Ahmed Nahid Elshaer,Abdullah Shaik,Irene Landi,Talal Alzahrani
BACKGROUND Data on race-related differences in the clinical outcomes of Takotsubo syndrome are limited, particularly for Black patients. This study aimed to assess whether race and sex may have an additional impact on the inpatient mortality of patients with Takotsubo syndrome. METHODS A total of 4,628 patients from the United States' National Inpatient Sample from 2012 to 2016 were identified; propensity
-
Critical Care Echocardiography-A Driven Approach to Undifferentiated Shock. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-16 Pedro Salinas,Jacqueline Sohn,José L Díaz-Gómez
The clinical approach to undifferentiated shock in critically ill patients should be revised to use modern, point-of-care tools that are readily available. With the increasing availability of 2-dimensional ultrasonography and advanced Doppler capabilities, a quick, simplified, and integrated stepwise approach to shock using critical care echocardiography is proposed. Evidence supports the feasibility
-
Polyploidy in Cardiomyocytes: Machine Learning for Single Cell Analyses. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-16 Jeremy Scott Mitchell,Mark Alan Sussman
-
External Iliac Artery Dissection Described on Duplex Ultrasonography. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-16 Shannon M McDonnell,Pegge M Halandras,Robert S Dieter
-
Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-12 Xian-Liang Tang,Roberto Bolli
-
In Memoriam: Paolo Angelini (1941-2023)-A Pioneer and World-Leading Expert in Coronary Artery Anomalies. A Tribute From the International Coronary Artery Anomalies Collaborative (ICAAC). Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-12 Christoph Gräni,Carlos M Mery,Silvana Molossi
-
Surgical Management of Giant Unruptured Left Sinus of Valsalva Aneurysm With Severe Aortic Regurgitation. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-10 Keisuke Ozawa,Kenji Kuwaki,Hidekazu Furuya,Masaomi Yamaguchi,Akiyoshi Yamamoto
Left sinus of Valsalva aneurysms are extremely rare. Concomitant aortic valve regurgitation is a comorbidity in this pathology. This case report summarizes successful surgical treatment with aortic root replacement with a modified Bentall procedure in a 49-year-old female patient who had an unruptured huge left sinus of Valsalva aneurysm with severe aortic valve regurgitation. The intraoperative assessment
-
Surgical Delivery of Embryonic Cells and Products. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-10-10 Philippe Menasché
-
Surgical Considerations for Left Ventricular Assist Device Implantation. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-28 Syed B Peer,Gabriel Loor
-
The Transition From Temporary to Durable Mechanical Circulatory Support: Surgical Considerations. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-28 Syed B Peer,Harveen K Lamba,Alexis E Shafii
-
Mitigating Diagnostic Errors With Point-of-Care Ultrasonography: A New Framework. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-25 Jayne Chirdo Taylor
-
Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-24 Harveen K. Lamba, Lucy D. Hart, Qianzi Zhang, Jackquelin M. Loera, Andrew B. Civitello, Ajith P. Nair, Mourad H. Senussi, Gabriel Loor, Kenneth K. Liao, Alexis E. Shafii, Subhasis Chatterjee
Background Postoperative respiratory failure is a major complication that affects up to 10% of patients who undergo cardiac surgery and has a high in-hospital mortality rate. Few studies have investigated whether patients who require tracheostomy for postoperative respiratory failure after continuous-flow left ventricular assist device (CF-LVAD) implantation have worse survival outcomes than patients
-
Optimization of Left Ventricular Assist Device Support. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-23 Arantxa G Suero,Lola X Xie
-
Perioperative Hemotherapy Management in Left Ventricular Assist Device Surgery. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-21 Arthur W Bracey
-
Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-21 Sedat Taş,Ümmü Taş
BACKGROUND COVID-19 may be a risk factor for developing cardiovascular autonomic dysfunction. Data are limited, however, on the association between heart rate variability, heart rate turbulence, and COVID-19. The aims of this study were to evaluate the effect of COVID-19 on the cardiovascular autonomic system in patients with persistent symptoms after recovering from COVID-19 and to determine whether
-
Sex-Based Differences in the Presentation and Outcomes of Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-14 Yu Zhang, Yu Qiu, Jinming Luo, Jian Zhang, Qingqing Yan
Background The study aimed to review differences in the presentation and outcomes of acute pulmonary embolism (PE) between men and women. Methods PubMed, CENTRAL, Web of Science, and Embase were searched for studies comparing clinical features or outcomes of PE between men and women. Baseline comorbidities, risk factors, clinical features, and mortality rates were also compared between men and women
-
Management of Vasoplegic Shock in Left Ventricular Assist Device Insertion Procedures. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-08 Subhasis Chatterjee
-
High-Sensitivity Cardiac Troponin T Variation After Percutaneous Atrial Septal Defect Closure. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-08-01 Alejandro E Contreras,Alejandro R Peirone,Facundo Ledesma,Ernesto Juaneda,Víctor Defagó,Eduardo Cuestas
-
Critical Care Echocardiography for Fluid Responsiveness. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-28 Maki Ishizuka,Erik Su
-
Coronary Ostial Acquired Occlusion or Congenital Atresia: An Ongoing Discussion Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-28 Divyansh Sharma, Abhisheik Prashar
Coronary ostial atresia is a developmental abnormality that typically causes asymptomatic anomalies in the coronary blood supply. This case report, which presents 2 symptomatic patients with right coronary artery abnormalities, explores difficulties in diagnosing coronary ostial atresia and distinguishing it from single coronary artery and coronary artery disease–related acquired occlusion. Factors
-
The Value of Strain Echocardiography in Predicting Electrical Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-24 Leila Hosseini,Nahid Rezaeian,Anita Sadeghpour,Zahra Amirajam,Hamid Farzamnia,Sanaz Asadian,Hooman Bakhshandeh,Sara Hosseini,Zahra Emkanjoo
BACKGROUND Arrhythmogenic right ventricular (RV) cardiomyopathy is a progressive disease characterized by the replacement of the normal myocardium with fibrofatty tissue. This study aimed to determine the value of echocardiographic RV deformation parameters in predicting electrical progression as assessed by serial changes in RV lead sensing and threshold in patients with arrhythmogenic RV cardiomyopathy
-
Advanced Perioperative Echocardiography in Venoarterial Extracorporeal Membrane Oxygenation Weaning Trial-Off. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-19 José L Díaz-Gómez,Alec A Hendon
-
Anticoagulation Management in Temporary Mechanical Circulatory Support Devices. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-19 Ellen B Yin
-
Cutting-Edge Physical Therapy in Mechanical Circulatory Support: Critical Care Physical Therapy Perspectives. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-17 Mia Frances H Tennant,Christiane Perme,Amy Butcher
-
Bail-Out Stent Graft Implantation for Wire Perforation of an Axillary Artery Branch. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Tomoki Fukui,Nobuyuki Ogasawara
-
Pearls in Anticoagulation Management for Patients With Left Ventricular Assist Devices. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Ellen Yin
-
Early Intraoperative Detection and Management of Right Ventricular Failure After Left Ventricular Assist Device Implantation. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Thomas R Powell
-
End-of-Life Issues in Patients With Left Ventricular Assist Devices. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Mary Acelle G Garcia,Astrid Grouls
-
Trigeminal Amyloidoma in a Patient With Cardiac Amyloidosis. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Nikita Jhawar,Razvan Chirila,Juan Carlos Leoni Moreno
Trigeminal amyloidoma is a rare clinical phenomenon with scarce reports in the medical literature. This report presents a case of biopsy-proven trigeminal amyloidoma in a patient with cardiac amyloidosis. This case report sheds light on the differential diagnoses that may resemble trigeminal amyloidoma and strategies for workup and treatment.
-
Evidence and Practicality of Real-Time Ultrasound-Guided Procedures in the Intensive Care Unit: A New Skill Set for the Intensivist. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-07-01 Jacqueline Sohn,Min Se Cha
-
Arterial Grafts in Coronary Artery Bypass Surgery: Who, When, and Why. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Natalia Roa-Vidal,Lauren K Barron
-
The James T. Willerson, MD, Editor's Choice Award. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Zvonimir Krajcer
-
Cutting-Edge Trials in Structural Heart Disease at The Texas Heart Institute. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Riyad Yazan Kherallah,Guilherme Silva
-
The Past, Present, and Future of Complex Aortic Intervention. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Joseph S Coselli
-
In Memoriam: Michael R. Nihill, MBBS (1936-2023). Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Wayne J Franklin,Colin J McMahon,Daniel J Penny
-
Leveraging Innovation to Mitigate Risk During Heart Surgery. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Marc R Moon,Puja Kachroo
-
Management of Cardiogenic Shock: Present and Future. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Nikolaos A Diakos
-
The Role of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Valves in 2023. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Milad El Hajj,Zvonimir Krajcer
-
Conduction System Pacing for Cardiac Resynchronization Therapy: The 31-Million-Dollar Question. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Jitae A Kim,Mihail G Chelu
-
A Novel Approach to Diagnostic Left and Right Heart Catheterization in a Patient With a Mechanical Prosthetic Tricuspid Valve. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Seulgi E Kim,Dhaval Parekh,Wilson Lam
A 47-year-old patient was experiencing dyspnea and fatigue concerning for right ventricular hypertension and new heart failure. Because of the risks associated with catheter entrapment, prosthetic valve leaflet damage, and valve thrombosis associated with crossing a mechanical valve, a novel technique was used for diagnostic left and right heart catheterization in a patient with mechanical tricuspid
-
P2Y12 Inhibitors for Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Tomohiro Fujisaki,Toshiki Kuno,Alexandros Briasoulis,Naoki Misumida,Hisato Takagi,Azeem Latib
BACKGROUND For patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), prasugrel was recommended over ticagrelor in a recent randomized controlled trial, although more data are needed on the rationale. Here, the effects of P2Y12 inhibitors on ischemic and bleeding events in patients with NSTE-ACS were investigated. METHODS Clinical trials that enrolled patients with NSTE-ACS were
-
Increased Plasma Non-High-Density Lipoprotein Levels and Poor Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Fatih Sivri,Banu Öztürk Ceyhan
BACKGROUND This study investigated the relationship between coronary collateral circulation (CCC) and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with stable coronary artery disease (CAD). Coronary collateral circulation plays a critical role in supporting blood flow, particularly in the ischemic myocardium. Previous studies show that non-HDL-C plays a more important role in the
-
Does the Type of Chronic Heart Failure Impact In-Hospital Outcomes for Aortic Valve Replacement Procedures? Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 Talha Mubashir,John Zaki,Sin Yeong An,Ismael A Salas De Armas,Yafen Liang,Travis Markham,Han Feng,Mehmet H Akay,Angelo Nascimbene,Bindu Akkanti,George W Williams,Fabricio Zasso,Maria Patarroyo Aponte,Igor D Gregoric,Biswajit Kar
BACKGROUND This study assessed in-hospital outcomes of patients with chronic systolic, diastolic, or mixed heart failure (HF) undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). METHODS The Nationwide Inpatient Sample database was used to identify patients with aortic stenosis and chronic HF who underwent TAVR or SAVR between 2012 and 2015. Propensity
-
Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia. Tex. Heart Inst. J. (IF 0.9) Pub Date : 2023-05-01 S Yukiko Asaki,David Kessler,Aarushi Nayak,Jeffrey J Kim,Christina Y Miyake
Catecholaminergic polymorphic ventricular tachycardia is a rare but lethal heritable arrhythmia syndrome associated with both atrial and ventricular arrhythmias. Treatment includes antiarrhythmics, sympathetic denervation, and implantable cardioverter-defibrillators. The use of atrioventricular nodal ablation as a treatment strategy to prevent ventricular arrhythmias in catecholaminergic polymorphic